T. Rowe Price Investment Management Inc. 13D and 13G filings for Acelyrin, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-03-07 12:49 pm Sale | 2025-02-28 | 13G | Acelyrin, Inc. SLRN | T. Rowe Price Investment Management Inc. | 4,651,030 4.600% | -8,221,094 (-63.87%) | Filing |
| 2025-02-14 09:45 am Purchase | 2024-12-31 | 13G | Acelyrin, Inc. SLRN | T. Rowe Price Investment Management Inc. | 12,872,124 12.800% | 2,440,278 (+23.39%) | Filing |
| 2024-11-14 1:28 pm Sale | 2024-09-30 | 13G | Acelyrin, Inc. SLRN | T. Rowe Price Investment Management Inc. | 10,431,846 10.500% | -67,054 (-0.64%) | Filing |
| 2024-09-10 1:49 pm Purchase | 2024-08-31 | 13G | Acelyrin, Inc. SLRN | T. Rowe Price Investment Management Inc. | 10,498,900 10.500% | 10,498,900 (New Position) | Filing |